Best Drug Manufacturers - General stocks: industry ranking by MarketKingdoms score

13 Drug Manufacturers - General companies are scored. Their average composite is 64.5, and 0 are in the A range (76+). The leader is Amgen Inc. (AMGN) at 72.1 (B+). This industry belongs to the Healthcare sector.

Drug Manufacturers - General lens averages

• Industry opportunity: 80
• Stock selection: 80
• KPI momentum: 77
• Catalyst watch: 76
• Price (valuation): 53
• Expansion (growth): 39
• Quality (profitability): 60
• Trend (momentum): 55

All Drug Manufacturers - General companies ranked

#	Company	Composite	Grade	Industry opportunity	Stock selection	KPI momentum	Catalyst watch	Price	Expansion	Quality	Trend	Valuation gap
1	Amgen Inc. (AMGN)	72.1	B+	80	90	99	75	41	44	66	80	+13.9%
2	Eli Lilly & Co. (LLY)	71.1	B+	80	86	99	72	22	92	67	74	+1.7%
3	AbbVie Inc. (ABBV)	68.9	B	80	86	92	75	43	77	68	70	-3.2%
4	Bristol-Myers Squibb Co. (BMY)	66.1	B	80	74	71	73	77	23	68	52	-11.0%
5	Biogen Inc. (BIIB)	65.7	B	80	81	79	81	50	30	49	83	+31.0%
6	Gilead Sciences Inc. (GILD)	65.4	B	80	82	81	77	39	27	44	68	-3.5%
7	GSK plc ADR (GSK)	62.9	B-	80	82	82	76	81	31	71	35	-5.1%
8	Novo Nordisk ADR (NVO)	62.8	B-	80	76	58	86	69	22	77	10	-24.0%
9	Novartis AG ADR (NVS)	62.0	B-	80	68	52	67	60	31	82	36	-3.9%
10	Sanofi ADR (SNY)	61.7	B-	80	80	72	74	79	47	48	17	-22.5%
11	Pfizer Inc. (PFE)	60.6	B-	80	81	77	79	60	6	38	63	+4.3%
12	Johnson & Johnson (JNJ)	60.3	B-	80	76	65	75	33	38	60	58	-2.6%
13	Merck & Co Inc. (MRK)	59.3	B-	80	76	74	80	36	40	43	73	-3.1%

Drug Manufacturers - General leaders on each lens

• Industry opportunity: ABBV 80, AMGN 80, BIIB 80
• Stock selection: AMGN 90, ABBV 86, LLY 86
• KPI momentum: AMGN 99, LLY 99, ABBV 92
• Catalyst watch: NVO 86, BIIB 81, MRK 80
• Price (valuation): GSK 81, SNY 79, BMY 77
• Expansion (growth): LLY 92, ABBV 77, SNY 47
• Quality (profitability): NVS 82, NVO 77, GSK 71
• Trend (momentum): BIIB 83, AMGN 80, LLY 74

How MarketKingdoms scores companies

The composite score (0–100, graded A+ to D-) blends research signals from each earnings call with fundamental lenses from SEC filings and market prices. Research signals: Industry opportunity, Stock selection, KPI momentum and Catalyst watch, read from what management said and whether it delivered. Fundamental lenses: Price (valuation), Expansion (growth), Quality (profitability) and Trend (momentum). Scores are recalculated every night and after every earnings call. The valuation gap compares the actual price path with the path the stock's market, sector and industry moves explain; it is a model comparison, not a fair-value estimate.

General information, not investment advice.